184 related articles for article (PubMed ID: 16958404)
1. Recurrent thymoma: radiological (CT and FDG-PET) and histological (WHO criteria) features.
Ito H; Shimada K; Isogami K; Kondo T; Kaneta T; Takahashi S; Fukuda H
Radiat Med; 2006 May; 24(4):292-6. PubMed ID: 16958404
[TBL] [Abstract][Full Text] [Related]
2. Clinical use of combined positron emission tomography and computed tomography in thymoma recurrence.
El-Bawab HY; Abouzied MM; Rafay MA; Hajjar WM; Saleh WM; Alkattan KM
Interact Cardiovasc Thorac Surg; 2010 Oct; 11(4):395-9. PubMed ID: 20639307
[TBL] [Abstract][Full Text] [Related]
3. The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours.
Fukumoto K; Taniguchi T; Ishikawa Y; Kawaguchi K; Fukui T; Kato K; Matsuo K; Yokoi K
Eur J Cardiothorac Surg; 2012 Dec; 42(6):e152-6. PubMed ID: 23024234
[TBL] [Abstract][Full Text] [Related]
4. 18F-fluorodeoxyglucose and 11C-acetate positron emission tomography are useful modalities for diagnosing the histologic type of thymoma.
Shibata H; Nomori H; Uno K; Sakaguchi K; Nakashima R; Iyama K; Tomiyoshi K; Kaji M; Goya T; Suzuki T; Horio H
Cancer; 2009 Jun; 115(11):2531-8. PubMed ID: 19326456
[TBL] [Abstract][Full Text] [Related]
5. FDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies.
Benveniste MF; Moran CA; Mawlawi O; Fox PS; Swisher SG; Munden RF; Marom EM
J Thorac Oncol; 2013 Apr; 8(4):502-10. PubMed ID: 23446204
[TBL] [Abstract][Full Text] [Related]
6. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: a preliminary report.
Liu RS; Yeh SH; Huang MH; Wang LS; Chu LS; Chang CP; Chu YK; Wu LC
Eur J Nucl Med; 1995 Dec; 22(12):1402-7. PubMed ID: 8586085
[TBL] [Abstract][Full Text] [Related]
7. Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology.
El-Bawab H; Al-Sugair AA; Rafay M; Hajjar W; Mahdy M; Al-Kattan K
Eur J Cardiothorac Surg; 2007 Apr; 31(4):731-6. PubMed ID: 17293120
[TBL] [Abstract][Full Text] [Related]
8. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms.
Terzi A; Bertolaccini L; Rizzardi G; Luzzi L; Bianchi A; Campione A; Comino A; Biggi A
Lung Cancer; 2011 Nov; 74(2):239-43. PubMed ID: 21439670
[TBL] [Abstract][Full Text] [Related]
10. Role of fluorine-flurodeoxyglucose positron emission tomography/computed tomography in preoperative assessment of anterior mediastinal masses.
Luzzi L; Campione A; Gorla A; Vassallo G; Bianchi A; Biggi A; Terzi A
Eur J Cardiothorac Surg; 2009 Sep; 36(3):475-9. PubMed ID: 19501523
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups.
Sung YM; Lee KS; Kim BT; Choi JY; Shim YM; Yi CA
J Nucl Med; 2006 Oct; 47(10):1628-34. PubMed ID: 17015898
[TBL] [Abstract][Full Text] [Related]
12. Imaging of a case of metaplastic thymoma on 18F-FDG PET/CT.
Ishikawa Y; Kato K; Taniguchi T; Kawaguchi K; Yokoi K
Clin Nucl Med; 2013 Dec; 38(12):e463-4. PubMed ID: 24212449
[TBL] [Abstract][Full Text] [Related]
13. F-18 FDG PET/CT demonstration of thymoma followed by development of lung cancer.
Choi JJ; Ahn MI; Park MY; Jeon JS; Park YH
Clin Nucl Med; 2008 Mar; 33(3):234-5. PubMed ID: 18287859
[TBL] [Abstract][Full Text] [Related]
14. Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors.
Endo M; Nakagawa K; Ohde Y; Okumura T; Kondo H; Igawa S; Nakamura Y; Tsuya A; Murakami H; Takahashi T; Yamamoto N; Ito I; Kameya T
Lung Cancer; 2008 Sep; 61(3):350-5. PubMed ID: 18304691
[TBL] [Abstract][Full Text] [Related]
15. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
Jadvar H; Henderson RW; Conti PS
J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
[TBL] [Abstract][Full Text] [Related]
16. Role of combined 18F-FDG-PET/CT for predicting the WHO malignancy grade of thymic epithelial tumors: a multicenter analysis.
Lococo F; Cesario A; Okami J; Cardillo G; Cavuto S; Tokunaga T; Apolone G; Margaritora S; Granone P
Lung Cancer; 2013 Nov; 82(2):245-51. PubMed ID: 23992878
[TBL] [Abstract][Full Text] [Related]
17. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
[TBL] [Abstract][Full Text] [Related]
18. Imaging of an invasive malignant thymoma on PET Scan: CT and histopathologic correlation.
Bagga S; Bloch EM
Clin Nucl Med; 2006 Oct; 31(10):614-6. PubMed ID: 16985366
[TBL] [Abstract][Full Text] [Related]
19. Advances in thymoma imaging.
Marom EM
J Thorac Imaging; 2013 Mar; 28(2):69-80; quiz 81-3. PubMed ID: 23422781
[TBL] [Abstract][Full Text] [Related]
20. 18-Fluorine fluorodeoxyglucose positron emission tomography in the pretreatment evaluation of thymic epithelial neoplasms: a metabolic biopsy confirmed by Ki-67 expression.
Viti A; Bertolaccini L; Cavallo A; Fortunato M; Bianchi A; Terzi A
Eur J Cardiothorac Surg; 2014 Sep; 46(3):369-74; discussion 374. PubMed ID: 24585679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]